Proteomics in brain research: Potentials and limitations

Progress in Neurobiology

Volumn 69, Issue 3, 2003, Pages 193-211

  Lubec, Gert ^a   Krapfenbauer, Kurt ^a,b   Fountoulakis, Michael ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ENZYME; BRAIN PROTEIN; CHAPERONE; CYTOSKELETON PROTEIN; HEAT SHOCK PROTEIN; PROTEOME; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR;

ARTICLE; BRAIN METABOLISM; HEALTH; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MASS SPECTROMETRY; MEDICAL RESEARCH; NEUROBIOLOGY; NEUROLOGIC DISEASE; NEUROSCIENCE; NEUROTOXICOLOGY; NUCLEIC ACID STRUCTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

EID: 0038025565     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(03)00036-4     Document Type: Article

References (98)

1. Adam G.C., Sorensen E.J., Cravatt B.F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol. 20:2002;805-809.
2. Bajo M., Yoo B.C., Cairns N., Gratzer M., Lubec G. Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease. Amino Acids. 21:2001;293-301.
3. Bajo M., Fruehauf J., Kim S.H., Fountoulakis M., Lubec G. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex. Proteomics. 2(11):2002;1539-1546.
4. Belghazi M., Bathany K., Hountondji C., Grandier-Vazeille X., Manon S., Schmitter J.M. Analysis of protein sequences and protein complexes by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics. 1:2001;946-954.
5. Bellanger S., Demeret C., Goyat S., Thierry F. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75:2001;7244-7251.
6. Berndt P., Hobolm U., Langen H. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis. 20:1999;3521-3526.
7. Bicknese A.R., Goodwin H.S., Quinn C.O., Henderson V.C., Chien S.N., Wall D.A. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant. 11:2002;261-264.
8. Bies J., Wolff L. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene. 14:1997;203-212.
9. Brookes P.S., Pinner A., Ramachandran A., Coward L., Barnes S., Kim H., Darley-Usmar V.M. High throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signalling complexes. Proteomics. 2:2002;969-977.
10. Celis J.E., Ostergaard M., Jensen N.A., Gromova I., Rasmussen H.H., Gromov P. Human and mouse proteomic databases: novel resources in the protein universe. FEBS Lett. 430:1998;64-72.
11. Chevallet M., Santoni V., Poinas A., Rouquié D., Fuchs A., Kiefer S., Rossignol M., Lunardi M., Garin J., Rabilloud T. New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis. Electrophoresis. 19:1998;1901-1909.
12. Csar X.F., Wilson N.J., Strike P., Sparrow L., McMahon K.A., Ward A.C., Hamilton J.A. Copper/zinc superoxide dismutase is phosphorylated and modulated specifically by granulocyte-colony stimulating factor in myeloid cells. Proteomics. 1:2001;435-443.
13. dos Remedios, C.G., Thomas, D.D., 2001. Molecular Interactions of Actin. Springer, Berlin, Heidelberg, pp. 231-254.
14. Dua K., Williams T.M., Beretta L. Translational control of the proteome: relevance to cancer. Proteomics. 1:2001;1191-1199.
15. Evers S., Di Padova K., Meyer M., Langen H., Fountoulakis M., Keck W., Gray C.P. Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors. Proteomics. 1:2001;522-544.
16. Ferro M., Seigneurin-Berny D., Rolland N., Chapel A., Salvi D., Garin J., Joyard J. Organic solvent extraction as a versatile provedure to identify hydrophobic chloroplast membrane proteins. Electrophoresis. 21:2000;3517-3526.
17. Fountoulakis, M., 2000. Two-dimensional electrophoresis. Encyclopedia of Separation Science, II/Electrophoresis. Academic Press, London, pp. 1356-1363.
18. Fountoulakis M. Proteomics: current technologies and applications in neurological disorders and toxicology. Amino Acids. 21:2001;363-381.
19. Fountoulakis M., Gasser R. Proteomic analysis of the cell envelope fraction of Escherichia coli. Amino Acids. 24:2003;19-41.
20. Fountoulakis M., Lahm H.-W. Hydrolysis and amino acid composition analysis of proteins. J. Chromatogr. 826:1998;109-134.
21. Fountoulakis M., Langen H. Identification of proteins by matrix-assisted laser desorption ionization-mass spectrometry following in-gel digestion in low-salt, nonvolatile buffer and simplified peptide recovery. Anal. Biochem. 250:1997;153-156.
22. Fountoulakis M., Takács B. Effect of strong detergents and chaotropes on the protein detection in two-dimensional gels. Electrophoresis. 22:2001;1593-1602.
23. Fountoulakis M., Takács B. Enrichment and proteomic analysis of low-abundance bacterial proteins. Methods Enzymol. 358:2002;288-306.
24. Fountoulakis M., Juranville J.-F., Berndt P. Large-scale identification of proteins of Haemophilus influenzae by amino acid composition analysis. Electrophoresis. 18:1997a;2968-2977.
25. Fountoulakis M., Langen H., Evers S., Gray C., Takács B. Two-dimensional map of Haemophilus influenzae following protein enrichment by Heparin chromatography. Electrophoresis. 18:1997b;1193-1202.
26. Fountoulakis M., Juranville J.-F., Roeder D., Evers S., Berndt P., Langen H. Reference map of the low-molecular-mass proteins of Haemophilus influenzae. Electrophoresis. 19:1998a;1819-1827.
27. Fountoulakis M., Langen H., Gray C., Takács B. Enrichment and purification of proteins of Haemophilus influenzae by chromatofocusing. J. Chromatogr. 806:1998b;279-291.
28. Fountoulakis M., Takács M.-F., Takács B. Enrichment of low-abundance proteins of Haemophilus influenzae by hydrophobic interaction chromatography. J. Chromatogr. 833:1999;157-168.
29. Fountoulakis M., Hardmeier R., Hoeger H., Lubec G. Postmortem changes in the level of brain proteins. Exp. Neurol. 167:2001;86-94.
30. Fratelli M., Demol H., Puype M., Casagrande S., Eberini I., Salmona M., Bonetto V., Mengozzi M., Duffieux F., Miclet E., Bachi A., Vandekerckhove J., Gianazza E., Ghezzi P. Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3505-3510.
31. Gevaert K., Candekerckhove J. Protein identification methods in proteomics. Electrophoresis. 21:2000;1145-1154.
32. Ghandour M.S., Langley O.K., Vincendon G., Combos G., Filippi D., Limozin N., Dalmasso D., Laurent G. Immunochemical and immunohistochemical study of carbonic anhydrase II in adult rat cerebellum: a marker for oligodendrocytes. Neuroscience. 5:1980;559-571.
33. Greber S., Lubec G., Cairns N., Fountoulakis M. Decreased levels of synaptosomal-associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis. 20:1999;928-934.
34. Gulesserian T., Seidl R., Hardmeier R., Cairns N., Lubec G. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome. J. Investig. Med. 49:2001;41-46.
35. Gulesserian T., Kim S.H., Fountoulakis M., Lubec G. Aberrant expression of centractin and capping proteins, integral constituents of the dynactin complex, in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 291:2002;62-67.
36. Guo X., Ying W., Wan J., Hu Z., Qian X., Zhang H., He F. Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro. Electrophoresis. 22:2001;3067-3075.
37. Hartinger J., Stenius K., Högemann D., Jahn R. 16-BAC/SDS-PAGE: a two-dimensional gel electrophoresis system suitable for the separation of integral membrane proteins. Anal. Biochem. 240:1996;126-133.
38. Hartl F.U., Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science. 295:2002;1852-1858.
39. Harvey D.J. Identification of protein-bound carbohydrates by mass spectrometry. Proteomics. 1:2001;311-328.
40. Hashimoto R., Nakamura Y., Imamura K., Nakadate K., Kashiwagi Y., Matsumoto N., Takeda M. Visual stimulation-induced phosphorylation of neurofilament-L in the visual cortex of dark-reared rats. Eur. J. Neurosci. 14:2001;1237-1245.
41. Henzel W.J., Billeci T.M., Stults J.T., Wong S.C., Grimley C., Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5011-5015.
42. Herbert B. Advances in protein solubilisation for two-dimensional electrophoresis. Electrophoresis. 20:1999;660-663.
43. Herbert B.R., Molloy M.P., Gooley A.A., Walsh B.J., Bryson W.G., Williams K.L. Improved protein solubility in two-dimensional electrophoresis using tributyl phosphine as reducing agent. Electrophoresis. 19:1998;845-851.
44. Hoang V.M., Foulk R., Clauser K., Burlingame A., Gibson B.W., Fisher S.J. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry. 40:2001;4077-4086.
45. Imam-Sghiouar N., Laude-Lemaire I., Labas V., Pflieger D., Le Caer J.P., Caron M., Nabias D.K., Joubert-Caron R. Subproteomics analysis of phospharylated proteins: application to the study of B-lymphoblasts from a patient with Scott syndrome. Proteomics. 1:2002;1092-1104.
46. Isaaq H.J. The role of separation science in proteomics research. Electrophoresis. 22:2001;3629-3638.
47. Is'harc H., Watling D., Kerr I.M. Phosphotyrosine profiling to identify novel components of interferon and interleukin 6-family cytokine signalling. Proteomics. 1:2001;767-772.
48. Jenkins R.E., Hawley S.R., Promwikorn W., Brown J., Hamlett J., Pennington S.R. Regulation of growth factor induced gene expression by calcium signalling integrated mRNA and protein expression analysis. Proteomics. 1:2001;1092-1104.
49. Jenkins L.W., Peter F.W., Dixon C.E., Zhang X., Clark R.S., Skinner J.C., Marion D.W., Adelson P.D., Kochanek P.M. Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 h after controlled cortical impact in postnatal day 17 rats. J. Neurotrauma. 19:2002;715-740.
50. Karlsson K., Cairns N., Lubec G., Fountoulakis M. Enrichment of human brain proteins by Heparin chromatography. Electrophoresis. 20:1999;2970-2976.
51. Klose J., Nock C., Herrmannm M., Stuhler K., Marcus K., Bluggel M., Krause E., Schalkwyk L.C., Rastan S., Brown S.D., Bussow K., Himmelbauer H., Lehrach H. Genetic analysis of the mouse brain proteome. Nat. Genet. 30:2002;385-393.
52. Kovarova H., Hajduch M., Korinkova G., Halada P., Krupickova S., Gouldsworthy A., Zhelev N., Strnad M. Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine. Electrophoresis. 21:2000;3757-3764.
53. Krapfenbauer K., Berger M., Friedlein A., Lubec G., Fountoulakis M. Changes in the levels of low-abundance brain proteins induced by kainic acid. Eur. J. Biochem. 268:2001a;3532-3537.
54. Krapfenbauer K., Berger M., Lubec G., Fountoulakis M. Changes in the brain protein levels following administration of kainic acid. Electrophoresis. 22:2001b;2086-2091.
55. Kuster B., Krogh T.N., Mortz E., Harvey D.J. Glycosylation analysis of gel-seperated proteins. Proteomics. 1:2001;350-361.
56. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:1982;105-132.
57. Lahm H.W., Langen H. Mass spectrometry: a tool for the identification of proteins separated by gels. Electrophoresis. 21:2000;2105-2114.
58. Langen H., Roeder D., Juranville J.-F., Fountoulakis M. Effect of the protein application mode and the acrylamide concentration on the resolution of protein spots separated by two-dimensional gel electrophoresis. Electrophoresis. 18:1997;2085-2090.
59. Langen H., Berndt P., Roder D., Cairns N., Lubec G., Fountoulakis M. Two-dimensional map of human brain proteins. Electrophoresis. 20:1999;907-916.
60. Le Naour F., Hohenkirk L., Grolleau A., Misek D.E., Lescure P., Geiger J.D., Hanash S., Beretta L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 276:2001;17920-17931.
61. Lewis T.S., Hunt J.B., Aveline L.D., Jonscher K.R., Louie D.F., Yeh J.M., Nahreini T.S., Resing K.A., Ahn N.G. Identification of novel MAP kinase pathway signalling targets by functional proteomics and mass spectrometry. Mol. Cell. 6:2000;1343-1354.
62. Li Y., Wei K., Lu C., Li Y., Li M., Xing G., Wei H., Wang Q., Chen J., Wu C., Chen H., Yang S., He F. Identification of hepatopoietin dimerization, its interacting regions and alternative splicing of its transcription. Eur. J. Biochem. 269:2002;3888-3893.
63. Lichtenfels R., Kellner R., Bukur J., Beck J., Brenner W., Ackermann A., Seliger B. Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics. 2:2002;561-570.
64. Lopez M.F., Kristal B.S., Chernokalskaya E., Lazarev A., Shestopalov A.I., Bogdanova A., Robinson M. High-througput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis. 21:2000;3427-3440.
65. Loughrey Chen S., Huddleston M.J., Shou W., Deshaies R.J., Annan R.S., Carr S.A. Mass spectrometry-based methods for phosphorylation site mapping of hyperphosphorylated proteins applied to Net1, a regulator of exit from mitosis in yeast. Mol. Cell Proteomics. 1:2002;186-196.
66. Lubec B., Weitzdoerfer R., Fountoulakis M. Manifold reduction of moesin in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 286:2001;1191-1194.
67. Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stepens G., Fitzgerald D.J. Identification of the phosphotyrosine proteome from thrombin-activated platelets. Proteomics. 2:2002;642-648.
68. Mann M., Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal. Chem. 66:1994;4390-4399.
69. Moller A., Malerczyk C., Volker U., Stoppler H., Maser E. Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis. Proteomics. 2:2002;697-705.
70. Molloy M.P. Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients. Anal. Biochem. 280:2000;1-10.
71. Nawrocki A., Fey S.J., Goffeau A., Roepstorff P., Larsen P.M. The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance. Proteomics. 1:2001;1022-1032.
72. Ohi M.D., Link A.J., Ren L., Jennings J.L., McDonald W.H., Gould K.L. Proteomics analysis reveals stable multiprotein complexes in both fission and budding yeasts containing Myb-related Cdc5p/Cef1p, novel pre-mRNA splicing factors, and snRNAs. Mol. Cell Biol. 22:2002;2011-2024.
73. Peyril A., Weitzdoerfer R., Gulesserian T., Fountoulakis M., Lubec G. Aberrant expression of signalling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21). Electrophoresis. 23:2002;152-157.
74. Quadroni M., James P. Proteomics and automation. Electrophoresis. 20:1999;664-677.
75. Rabilloud T., Blisnick T., Heller M., Luche S., Aebersold R., Lunardi J., Braun-Breton C. Analysis of membrane proteins by two-dimensional electrophoresis: comparison of the proteins extracted from normal or Plasmodium falciparum-infected erythrocyte ghosts. Electrophoresis. 20:1999;3603-3610.
76. Rabilloud T., Heller M., Rigobello M.P., Bindoli A., Aebersold R., Lunardi J. The mitochondrial antioxidant defence system and ist response to oxidative stress. Proteomics. 1:2001;1105-1110.
77. Rabilloud T., Heller M., Gasner F., Luche S., Rey C., Aebersold R., Benahmed M., Louisot P., Lunardi J. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277:2002a;19396-19401.
78. Rabilloud T., Strub J.M., Carte N., Luche S., Van Dorsselaer A., Lunardi J., Giege R., Florentz C. Comparative proteomics as a new tool for exploring human mitochondrial tRNA disorders. Biochemistry. 8:2002b;144-150.
79. Sanders S.L., Jennings J., Canutescu A., Link A.J., Weil P.A. Proteomics of the eukaryotic transcription machinery: identification of proteins associated with components of yeast TFIID by multidimensional mass spectrometry. Mol. Cell Biol. 22:2002;4723-4738.
80. Santoni V., Molloy M., Rabilloud T. Membrane proteins and proteomics: un amour impossible? Electrophoresis. 21:2000;1054-1070.
81. Schuller E., Gulesserian T., Seidl R., Cairns N., Lubec G. Brain t-complex polypeptide 1 (TCP-1) related to its natural substrate beta1 tubulin is decreased in Alzheimer's disease. Life Sci. 69:2001;263-270.
82. Seow T.K., Korke R., Liang R.C., Ong S.E., Ou K., Wong K., Hu W.S., Chung M.C. Proteomic investigation of metabolic shift in mammalian cell culture. Biotechnol. Prog. 17:2001;1137-1144.
83. Simpson R.J., Dorow D.S. Cancer proteomics: from signalling networks to tumor markers. Trends Biotechnol. 19:2001;S40-S48.
84. Skynner H.A., Rosahl T.W., Knowles M.R., Salim K., Reid L., Cothliff R., McAllister G., Guest P.C. Alterations of stress related proteins in genetically altered mice revealed by two-dimensional differential in-gel electrophoresis analysis. Proteomics. 2:2002;1018-1025.
85. Soskic V., Gorlach M., Pounanovic S., Boehmer F.D., Godovac-Zimmermann J. Functional proteomics analysis of signal transduction pathways of the platelet-derived growth factor beta receptor. Biochemistry. 38:1999;1757-1764.
86. Srinivasan S., Traini M., Herbert B., Sexton D., Harry J., Alexander H., Williams K.L., Alexander S. Proteomic analysis of a developmentally regulated secretory vesicle. Proteomics. 1:2001;1119-1127.
87. Steiner S., Gatlin C.L., Lennon J.J., McGrath A.M., Aponte A.M., Makusky A.J., Rohrs M.C., Anderson N.L. Proteomics to display lovastatin-induced protein and pathway regulation in rat liver. Electrophoresis. 21:2000;2127-2137.
88. Tan C., Li J., Wang J., Xiang Q., Zhang X., Dong L., Shen S., Liang S., Li G. Proteomic analysis of differential protein expression in human nasopharyngeal carcinoma cells induced by NAG7 transfection. Proteomics. 2:2002;306-312.
89. Van Rossum A.J., Brophy P.M., Tait A., Barrett J., Jefferies J.R. Proteomic identification of glutathione S-transferases from the model nematode Caenorhabditis elegans. Proteomics. 1:2001;1463-1468.
90. Verma R., Chen S., Feldman R., Schieltz D., Yates J., Dohmen J., Deshaies R.J. Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol. Biol. Cell. 11:2000;3425-3439.
91. Vlkolinsky R., Cairns N., Fountoulakis M., Lubec G. Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol. Aging. 22:2001;547-553.
92. Weitzdoerfer R., Dierssen M., Fountoulakis M., Lubec G. Fetal life in Down syndrome starts with normal neuronal density but impaired dendritic spines and synaptosomal structure. J. Neural Transm. Suppl. 61:2001;59-70.
93. Weitzdoerfer R., Fountoulakis M., Lubec G. Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain. Biochem. Biophys. Res. Commun. 293:2002;836-841.
94. Yanagida M., Shimamoto A., Nishikawa K., Furuichi Y., Isobe T., Takahashi N. Isolation and proteomic characterization of the major proteins of the nucleolin-binding ribonucleoprotein complexexes. Proteomics. 1:2001;1390-1404.
95. Yoo B.C., Cairns N., Foutnoulakis M., Lubec G. Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12:2001a;219-225.
96. Yoo B.C., Kim S.H., Cairns N., Fountoulakis M., Lubec G. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 280:2001b;249-258.
97. Yoo B.C., Vlkolinsky R., Engidawork E., Cairns N., Fountoulakis M., Lubec G. Differential expression of molecular chaperones in brain of patients with Down syndrome. Electrophoresis. 22:2001c;1233-1241.
98. Zhao J., Tenev T., Martins L.M., Downward J., Lemoine N.R. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell Sci. 113:2000;4363-4371.